These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 1818332

  • 21. Antimicrotubular drugs binding to vinca domain of tubulin.
    Gupta S, Bhattacharyya B.
    Mol Cell Biochem; 2003 Nov; 253(1-2):41-7. PubMed ID: 14619954
    [Abstract] [Full Text] [Related]

  • 22. Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle.
    Jordan A, Hadfield JA, Lawrence NJ, McGown AT.
    Med Res Rev; 1998 Jul; 18(4):259-96. PubMed ID: 9664292
    [Abstract] [Full Text] [Related]

  • 23. Natural products which interact with tubulin in the vinca domain: maytansine, rhizoxin, phomopsin A, dolastatins 10 and 15 and halichondrin B.
    Hamel E.
    Pharmacol Ther; 1992 Jul; 55(1):31-51. PubMed ID: 1287674
    [Abstract] [Full Text] [Related]

  • 24. Mechanism of action cryptophycin. Interaction with the Vinca alkaloid domain of tubulin.
    Smith CD, Zhang X.
    J Biol Chem; 1996 Mar 15; 271(11):6192-8. PubMed ID: 8626409
    [Abstract] [Full Text] [Related]

  • 25. Differential effects of active isomers, segments, and analogs of dolastatin 10 on ligand interactions with tubulin. Correlation with cytotoxicity.
    Bai R, Roach MC, Jayaram SK, Barkoczy J, Pettit GR, Ludueña RF, Hamel E.
    Biochem Pharmacol; 1993 Apr 06; 45(7):1503-15. PubMed ID: 8471072
    [Abstract] [Full Text] [Related]

  • 26. Localization of the antimitotic peptide and depsipeptide binding site on beta-tubulin.
    Mitra A, Sept D.
    Biochemistry; 2004 Nov 09; 43(44):13955-62. PubMed ID: 15518544
    [Abstract] [Full Text] [Related]

  • 27. Diazonamide A and a synthetic structural analog: disruptive effects on mitosis and cellular microtubules and analysis of their interactions with tubulin.
    Cruz-Monserrate Z, Vervoort HC, Bai R, Newman DJ, Howell SB, Los G, Mullaney JT, Williams MD, Pettit GR, Fenical W, Hamel E.
    Mol Pharmacol; 2003 Jun 09; 63(6):1273-80. PubMed ID: 12761336
    [Abstract] [Full Text] [Related]

  • 28. Characterization of the interaction of TZT-1027, a potent antitumor agent, with tubulin.
    Natsume T, Watanabe J, Tamaoki S, Fujio N, Miyasaka K, Kobayashi M.
    Jpn J Cancer Res; 2000 Jul 09; 91(7):737-47. PubMed ID: 10920282
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Vinca site agents induce structural changes in tubulin different from and antagonistic to changes induced by colchicine site agents.
    Sackett DL.
    Biochemistry; 1995 May 30; 34(21):7010-9. PubMed ID: 7766610
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Interactions of tubulin with guanine nucleotides that have paclitaxel-like effects on tubulin assembly: 2',3'-dideoxyguanosine 5'-[alpha,beta-methylene]triphosphate, guanosine 5'-[alpha,beta-methylene]triphosphate, and 2',3'-dideoxyguanosine 5'-triphosphate.
    Hamel E, Vaughns J, Getahun Z, Johnson R, Lin CM.
    Arch Biochem Biophys; 1995 Oct 01; 322(2):486-99. PubMed ID: 7574725
    [Abstract] [Full Text] [Related]

  • 33. Maytansine inhibits nucleotide binding at the exchangeable site of tubulin.
    Huang AB, Lin CM, Hamel E.
    Biochem Biophys Res Commun; 1985 May 16; 128(3):1239-46. PubMed ID: 4004859
    [Abstract] [Full Text] [Related]

  • 34. Interaction of rhizoxin with bovine brain tubulin.
    Sullivan AS, Prasad V, Roach MC, Takahashi M, Iwasaki S, Ludueña RF.
    Cancer Res; 1990 Jul 15; 50(14):4277-80. PubMed ID: 2364385
    [Abstract] [Full Text] [Related]

  • 35. Structural insight into the inhibition of tubulin by vinca domain peptide ligands.
    Cormier A, Marchand M, Ravelli RB, Knossow M, Gigant B.
    EMBO Rep; 2008 Nov 15; 9(11):1101-6. PubMed ID: 18787557
    [Abstract] [Full Text] [Related]

  • 36. Vinca alkaloid-induced tubulin spiral formation correlates with cytotoxicity in the leukemic L1210 cell line.
    Lobert S, Fahy J, Hill BT, Duflos A, Etievant C, Correia JJ.
    Biochemistry; 2000 Oct 03; 39(39):12053-62. PubMed ID: 11009620
    [Abstract] [Full Text] [Related]

  • 37. Divalent cation and ionic strength effects on Vinca alkaloid-induced tubulin self-association.
    Lobert S, Boyd CA, Correia JJ.
    Biophys J; 1997 Jan 03; 72(1):416-27. PubMed ID: 8994628
    [Abstract] [Full Text] [Related]

  • 38. Cryptophycin 1 binds to tubulin at a site distinct from the colchicine binding site and at a site that may overlap the vinca binding site.
    Mooberry SL, Taoka CR, Busquets L.
    Cancer Lett; 1996 Oct 01; 107(1):53-7. PubMed ID: 8913266
    [Abstract] [Full Text] [Related]

  • 39. Role of guanine nucleotides in the vinblastine-induced self-association of tubulin: effects of guanosine alpha,beta-methylenetriphosphate and guanosine alpha,beta-methylenediphosphate.
    Vulevic B, Lobert S, Correia JJ.
    Biochemistry; 1997 Oct 21; 36(42):12828-35. PubMed ID: 9335540
    [Abstract] [Full Text] [Related]

  • 40. Modulation of microtubule dynamics by drugs: a paradigm for the actions of cellular regulators.
    Wilson L, Panda D, Jordan MA.
    Cell Struct Funct; 1999 Oct 21; 24(5):329-35. PubMed ID: 15216890
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.